The effectiveness and safety of preoperative use of erythropoietin in patients scheduled for total hip or knee arthroplasty: A systematic review and meta-analysis of randomized controlled trials

INTRODUCTION: Because allogeneic blood transfusion carries a risk of serious complications, erythropoietin (EPO) has been used in patients scheduled for total hip or knee arthroplasty in an effort to reduce the need for allogeneic blood transfusion; however, its efficacy, cost-effectiveness, and saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yan, Jiang, Chao, Peng, Huiming, Feng, Bin, Li, Yulong, Weng, Xisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058850/
https://www.ncbi.nlm.nih.gov/pubmed/27399121
http://dx.doi.org/10.1097/MD.0000000000004122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058850/
https://www.ncbi.nlm.nih.gov/pubmed/27399121
http://dx.doi.org/10.1097/MD.0000000000004122

Ejemplares similares